Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | GLA | P06280 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | AR | P10275 | 5/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | TNKS2 | Q9H2K2 | 7/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | TNKS | O95271 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18486021 | 1.00 | KDM4E (0.42) | KDM4EGLAGAAHPGDALDH1A1 | |
| SCHEMBL18485991 | 0.90 | AR (0.37) | KDM4EGLAGAAHPGDALDH1A1 | |
| SCHEMBL18486054 | 0.90 | AR (0.37) | KDM4EGLAGAAHPGDALDH1A1 | |
| SCHEMBL18485982 | 0.88 | AR (0.37) | AR | |
| SCHEMBL18486039 | 0.88 | AR (0.37) | AR | |
| SCHEMBL18486081 | 0.87 | AR (0.37) | KDM4EHPGDALDH1A1ARTP53 | |
| SCHEMBL18486015 | 0.87 | AR (0.37) | KDM4EHPGDALDH1A1ARTP53 | |
| SCHEMBL18486026 | 0.87 | AR (0.36) | AR | |
| SCHEMBL18486112 | 0.87 | AR (0.36) | AR | |
| SCHEMBL18486040 | 0.86 | AR (0.36) | AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3130596-B1 | GLUCOSE DERIVATIVE, AND CELL IMAGING METHOD AND IMAGING AGENT USING SAID DERIVATIVE | UNIV HIROSAKI (JP) | 2021-01-20 | — | — | EP | claimed |
| US-10001487-B2 | Glucose derivative, and cell imaging method and imaging agent using said derivative | HIROSAKI UNIVERSITY (JP) | 2018-06-19 | — | — | US | claimed |
| US-20170122955-A1 | NOVEL GLUCOSE DERIVATIVE, AND CELL IMAGING METHOD AND IMAGING AGENT USING SAID DERIVATIVE | HIROSAKI UNIVERSITY (JP) | 2017-05-04 | — | — | US | claimed |
| EP-3130596-A1 | NOVEL GLUCOSE DERIVATIVE, AND CELL IMAGING METHOD AND IMAGING AGENT USING SAID DERIVATIVE | Hirosaki University (JP) | 2017-02-15 | — | — | EP | claimed |
| US-20180238899-A1 | NOVEL GLUCOSE DERIVATIVE, AND CELL IMAGING METHOD AND IMAGING AGENT USING SAID DERIVATIVE | HIROSAKI UNIVERSITY (JP) | 2018-08-23 | — | — | US | disclosed |
| US-10001487-B2 | Glucose derivative, and cell imaging method and imaging agent using said derivative | HIROSAKI UNIVERSITY (JP) | 2018-06-19 | — | — | US | disclosed |
| US-20170122955-A1 | NOVEL GLUCOSE DERIVATIVE, AND CELL IMAGING METHOD AND IMAGING AGENT USING SAID DERIVATIVE | HIROSAKI UNIVERSITY (JP) | 2017-05-04 | — | — | US | disclosed |
| EP-3130596-A1 | NOVEL GLUCOSE DERIVATIVE, AND CELL IMAGING METHOD AND IMAGING AGENT USING SAID DERIVATIVE | Hirosaki University (JP) | 2017-02-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170122955-A1 | NOVEL GLUCOSE DERIVATIVE, AND CELL IMAGING METHOD AND IMAGING AGENT USING SAID DERIVATIVE | SLC2A4, SLC2A1, UGGT1 | KDM4E 2736/4885GLA 479/4885GAA 459/4885 |
| US-10001487-B2 | Glucose derivative, and cell imaging method and imaging agent using said derivative | SLC2A4, SLC2A1, G6PD | KDM4E 2987/4885GLA 422/4885GAA 482/4885 |
| US-20180238899-A1 | NOVEL GLUCOSE DERIVATIVE, AND CELL IMAGING METHOD AND IMAGING AGENT USING SAID DERIVATIVE | SLC2A4, SLC2A1, UGGT1 | KDM4E 2730/4885GLA 473/4885GAA 454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.